Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Labcorp Holdings Inc (NYSE: LH) was $248.14 for the day, down -4.45% from the previous closing price of $259.69. In other words, the price has decreased by -$4.45 from its previous closing price. On the day, 1.54 million shares were traded. LH stock price reached its highest trading level at $259.755 during the session, while it also had its lowest trading level at $248.04.
Ratios:
Our analysis of LH’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.93. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.67.
On April 02, 2025, Redburn Atlantic started tracking the stock assigning a Buy rating and target price of $276.
Citigroup Upgraded its Neutral to Buy on March 04, 2025, whereas the target price for the stock was revised from $250 to $300.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 13 ’25 when van der Vaart Sandra D sold 3,903 shares for $271.42 per share. The transaction valued at 1,059,371 led to the insider holds 2,274 shares of the business.
van der Vaart Sandra D bought 3,903 shares of LH for $1,059,371 on Aug 13 ’25. On Aug 11 ’25, another insider, Schechter Adam H, who serves as the President & CEO of the company, sold 5,643 shares for $266.78 each. As a result, the insider received 1,505,440 and left with 93,319 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LH now has a Market Capitalization of 20595619840 and an Enterprise Value of 26543519744. As of this moment, Labcorp’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.37, and their Forward P/E ratio for the next fiscal year is 14.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.50 while its Price-to-Book (P/B) ratio in mrq is 2.37. Its current Enterprise Value per Revenue stands at 1.928 whereas that against EBITDA is 13.394.
Stock Price History:
The Beta on a monthly basis for LH is 0.90, which has changed by 0.08704603 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, LH has reached a high of $293.72, while it has fallen to a 52-week low of $209.38. The 50-Day Moving Average of the stock is -10.67%, while the 200-Day Moving Average is calculated to be -2.73%.
Shares Statistics:
LH traded an average of 544.28K shares per day over the past three months and 868240 shares per day over the past ten days. A total of 83.00M shares are outstanding, with a floating share count of 82.83M. Insiders hold about 0.32% of the company’s shares, while institutions hold 99.37% stake in the company. Shares short for LH as of 1760486400 were 2438588 with a Short Ratio of 4.48, compared to 1757894400 on 2495734. Therefore, it implies a Short% of Shares Outstanding of 2438588 and a Short% of Float of 3.82.
Dividends & Splits
With its trailing 12-month dividend rate of 0.72, LH has a forward annual dividend rate of 2.88. Against a Trailing Annual Dividend Yield of 0.0027725366. The current Payout Ratio is 32.58% for LH, which recently paid a dividend on 2025-08-28 with an ex-dividend date of 2025-11-26. Stock splits for the company last occurred on 2023-07-03 when the company split stock in a 1164:1000 ratio.
Earnings Estimates
Labcorp Holdings Inc (LH) is presently subject to a detailed evaluation by 14.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $4.1, with high estimates of $4.3 and low estimates of $3.98.
Analysts are recommending an EPS of between $16.41 and $16.16 for the fiscal current year, implying an average EPS of $16.31. EPS for the following year is $17.56, with 19.0 analysts recommending between $18.21 and $16.86.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 12 analysts. It ranges from a high estimate of $3.61B to a low estimate of $3.54B. As of. The current estimate, Labcorp Holdings Inc’s year-ago sales were $3.33BFor the next quarter, 12 analysts are estimating revenue of $3.5B. There is a high estimate of $3.54B for the next quarter, whereas the lowest estimate is $3.46B.
A total of 17 analysts have provided revenue estimates for LH’s current fiscal year. The highest revenue estimate was $14.04B, while the lowest revenue estimate was $13.96B, resulting in an average revenue estimate of $14B. In the same quarter a year ago, actual revenue was $13.01BBased on 17 analysts’ estimates, the company’s revenue will be $14.62B in the next fiscal year. The high estimate is $14.88B and the low estimate is $14.4B.
